Hida M, Takamiya T, Kitajima N, Hiraga S, Satoh T
Department of Transplantation, School of Medicine, Tokai University, Japan.
Tokai J Exp Clin Med. 1986 Nov;11(5):335-8.
We performed both free and albumin-bound bilirubin removal therapy using the Evaflux-2A and evaluated its clinical effects. The removal rates of total bilirubin in the first and second sessions were 31.4%, and 31.0%, respectively. Our clinical data suggested that plasma exchange using Evaflux-2A and an albumin-added electrolyte solution as the substitute fluid was useful in the treatment of hyperbilirubinemia.
我们使用Evaflux-2A进行了游离胆红素和白蛋白结合胆红素清除治疗，并评估了其临床效果。第一次和第二次治疗期间总胆红素的清除率分别为31.4%和31.0%。我们的临床数据表明，使用Evaflux-2A和添加白蛋白的电解质溶液作为置换液进行血浆置换对高胆红素血症的治疗是有效的。
